ear infrared laser confocal endomicroscopy of the human liver.

Not Applicable

Recruiting

• Conditions: iver disease: fibrosis, cirrhosis, steatosis, inflammation; Liver disease: fibrosis, cirrhosis, steatosis, inflammation; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12608000152325
• Lead Sponsor: Optiscan Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-03-31
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Patients indicated for laparoscopic liver assessment as determined by the attending hepatologist, age >18 years, a negative pregnancy test, written informed consent.

Exclusion Criteria

Patients under the age of 18 years.
Patients with blood coagulation disorders (Quick's test <50%; PTT>50s; platelets <50.000/nl), impaired renal function (serum creatinine >1.2mg/dl), lack of liver visualisation by ultrasonography, uncontrolled ascites or hyperthyreosis.
Patients unable to give informed consent. Women who are pregnant or breast-feeding.
Patients with known allergy or prior adverse reaction to Indocyanine Green.

Study & Design

• Study Type: Interventional
• Study Design: Not specified